Combining leptin treatment with leptin sensitizers may thus help overcome leptin resistance and, also obesity, as a result [14]
mechanism unexplained Relative contributions of direct peptide effects versus downstream IGF-1 actions inadequately characterized Long-term receptor sensitivity and potential for desensitization inadequately studied Individual patient variability in response not well-characterized Potential for differential effects based on endogenous growth hormone status unclear Long-Term Safety Considerations Critical safety questions remain unanswered regarding chronic peptide administration: Cardiovascular safety concerns FDA warnings cite risks of increased heart rate, systemic vasodilation, flushing, and transient hypotension Immunogenicity risks FDA identifies both peptides as potentially immunogenic with risk of serious immune reactions including anaphylaxis Cancer risk theoretical concern that chronic growth hormone/IGF-1 elevation could promote cellular proliferation
It helps support muscle health, and you get a lot of protein for relatively few calories
That means its possible that some other factor besides the GLP-1s themselves accounted for the positive findings
Immune-related adverse events and their management in peptide-based therapies. Therapeutic Advances in Chronic Disease , 7(4), 192208
Ledge test The ledge test is a specific test to evaluate the ability of motor coordination in mice 117